Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

John Day

Professor of Neurology and Pediatrics

Stanford University

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (13)

Yi Zeng

Stanford University

UNITED STATES

View details

Tahereh Kamali

Stanford University

UNITED STATES

View details

Robert Graham

Senior Associate in Critical Care Medicine

Boston Children's Hospital

UNITED STATES

View details

Charlotte Sumner

Professor

Johns Hopkins University

UNITED STATES

View details

Seth A. Hollander

UNITED STATES

View details

Meredith K James

UNITED KINGDOM

View details

Danielle Ramsey

Senior Lecturer in Physiotherapy

University of Suffolk

UNITED KINGDOM

View details

Evelin Milev

University College London

UNITED KINGDOM

View details

Deipanjan Nandi

Assistant Professor, Heart Failure & Transplant

Nationwide Children's Hospital

UNITED STATES

View details

Anna Capasso

Agostino Gemelli University Polyclinic

ITALY

View details

Tina Duong

Stanford University

UNITED STATES

View details

Andrea Klein

Head of Pediatric Neurology

Inselspital Universitätsspital Bern

SWITZERLAND

View details

Aaron Gitler

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Day

Research Interests

Explore related searches

Articles (20)

Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.

Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial

High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial

Identification of prognostic biomarkers in a large cohort of patients with LGMD R2.

Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS.

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale

Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.

An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.

DEVOTE part C results: exploring higher doses of nusinersen in nusinersenexperienced participants with spinal muscular atrophy (SMA)

Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1

MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility.

Integrating cognition and neuroimaging: a study of cerebral regions in myotonic dystrophy

Longitudinal assessment of 4-year HFMSE changes in SMA II and III patients treated with nusinersen

Patterns of volume and fat infiltration in skeletal muscle of adults with spinal muscular atrophy

Prediction of VO2max and cardiopulmonary responses from ventilatory threshold VO2 in neuromuscular disease patients using machine learning

Video-based biomechanical analysis captures disease-specific movement signatures of myotonic dystrophy and facioscapulohumeral muscular dystrophy

Evaluating oxygen saturation and recovery dynamics in skeletal muscle during exercise in adults with spinal muscular atrophy

3-Year functional outcomes of patients with Duchenne muscular dystrophy: pooled delandistrogene moxeparvovec clinical trial data vs external controls

Collaborators (13)

Yi Zeng

Tahereh Kamali

Robert Graham

Charlotte Sumner

Seth A. Hollander

Meredith K James

Danielle Ramsey

Evelin Milev

Deipanjan Nandi

Anna Capasso

Tina Duong

Andrea Klein

Aaron Gitler

Make your next move.